Cigna Group (CI) stock
CINYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3023% below fair value
$297.00+0.73 (+0.25%)
Close on Nov 13, 2026Market cap $78.48BP/E 13.1Yield 2.03%
Cigna revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Cigna's revenue for the twelve months ending Sep 30, 2026 was $286.32B, up 6.8% year over year. For fiscal 2025 it was $274.90B, up 11.2% from the year before. The highest annual figure on record is $274.90B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $274.90B | +11.2% |
| FY2024 | Dec 31, 2024 | $247.12B | +26.6% |
| FY2023 | Dec 31, 2023 | $195.27B | +8.2% |
| FY2022 | Dec 31, 2022 | $180.52B | +3.7% |
| FY2021 | Dec 31, 2021 | $174.07B | +8.5% |
| FY2020 | Dec 31, 2020 | $160.40B | +4.5% |
| FY2019 | Dec 31, 2019 | $153.57B | +215.7% |
| FY2018 | Dec 31, 2018 | $48.65B | +16.4% |
| FY2017 | Dec 31, 2017 | $41.81B | +4.9% |
| FY2016 | Dec 31, 2016 | $39.84B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $73.68B | +5.6% |
| Q2 FY2026 | Jun 30, 2026 | $71.67B | +6.7% |
| Q1 FY2026 | Mar 31, 2026 | $68.49B | +4.6% |
| Q4 FY2025 | Dec 31, 2025 | $72.47B | +10.4% |
| Q3 FY2025 | Sep 30, 2025 | $69.75B | +9.5% |
| Q2 FY2025 | Jun 30, 2025 | $67.18B | +11.0% |
| Q1 FY2025 | Mar 31, 2025 | $65.50B | +14.4% |
| Q4 FY2024 | Dec 31, 2024 | $65.65B | +28.4% |
| Q3 FY2024 | Sep 30, 2024 | $63.69B | +29.9% |
| Q2 FY2024 | Jun 30, 2024 | $60.52B | +24.6% |
| Q1 FY2024 | Mar 31, 2024 | $57.26B | +23.1% |
| Q4 FY2023 | Dec 31, 2023 | $51.11B | +11.7% |
| Q3 FY2023 | Sep 30, 2023 | $49.05B | +8.3% |
| Q2 FY2023 | Jun 30, 2023 | $48.59B | +6.8% |
| Q1 FY2023 | Mar 31, 2023 | $46.52B | +5.7% |
| Q4 FY2022 | Dec 31, 2022 | $45.75B | +0.2% |
| Q3 FY2022 | Sep 30, 2022 | $45.28B | +2.2% |
| Q2 FY2022 | Jun 30, 2022 | $45.48B | +5.4% |
| Q1 FY2022 | Mar 31, 2022 | $44.01B | +7.4% |
| Q4 FY2021 | Dec 31, 2021 | $45.68B | +9.5% |
| Q3 FY2021 | Sep 30, 2021 | $44.29B | +8.1% |
| Q2 FY2021 | Jun 30, 2021 | $43.13B | +9.8% |
| Q1 FY2021 | Mar 31, 2021 | $40.97B | +6.5% |
| Q4 FY2020 | Dec 31, 2020 | $41.71B | +9.1% |
| Q3 FY2020 | Sep 30, 2020 | $40.96B | +6.2% |
| Q2 FY2020 | Jun 30, 2020 | $39.27B | +1.1% |
| Q1 FY2020 | Mar 31, 2020 | $38.47B | +1.4% |
| Q4 FY2019 | Dec 31, 2019 | $38.25B | +167.4% |
| Q3 FY2019 | Sep 30, 2019 | $38.56B | +236.5% |
| Q2 FY2019 | Jun 30, 2019 | $38.82B | +238.1% |
| Q1 FY2019 | Mar 31, 2019 | $37.95B | +232.5% |
| Q4 FY2018 | Dec 31, 2018 | $14.30B | +34.5% |
| Q3 FY2018 | Sep 30, 2018 | $11.46B | +10.5% |
| Q2 FY2018 | Jun 30, 2018 | $11.48B | +10.7% |
| Q1 FY2018 | Mar 31, 2018 | $11.41B | +9.4% |
| Q4 FY2017 | Dec 31, 2017 | $10.63B | – |
| Q3 FY2017 | Sep 30, 2017 | $10.37B | – |
| Q2 FY2017 | Jun 30, 2017 | $10.37B | – |
| Q1 FY2017 | Mar 31, 2017 | $10.43B | – |
See a number that looks wrong?